Navigation Links
arGEN-X Presents Significant Progress at BioPharm America 2011
Date:9/7/2011

ROTTERDAM, The Netherlands, September 7, 2011 /PRNewswire/ --

SIMPLE Antibody™ platform continues to demonstrate clear advantages in therapeutic antibody discovery


arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies using its proprietary SIMPLE Antibody™ platform, will provide an update on this year's significant corporate progress  during a presentation by its CEO Tim Van Hauwermeiren at the BioPharm America conference in Boston, MA, USA (http://www.ebdgroup.com/bpa/).

In his presentation on Friday, September 9, Mr. Van Hauwermeiren will showcase the speed with which arGEN-X has developed its pipeline of novel therapeutic antibody candidates in cancer and inflammatory disease. In less than two years of operations, the Company has identified three completely novel lead antibodies of unprecedented specificity and potency and progressed them into preclinical studies. arGEN-X is also combining the power of its SIMPLE Antibody™ platform with POTELLIGENT® Technology licensed from BioWa, Inc., to increase the cytotoxic potency of its therapeutic leads even further.

The arGEN-X presentation will also announce the successful fulfilment of all milestones in its first biopharma collaboration, only five months from its initiation in January 2011. Upon completion of this program, arGEN-X delivered a panel of unique, diverse antibodies against a technically complex target provided by the partner. This success demonstrated how the SIMPLE Antibody™ platform could generate antibodies with outstanding qualities, even against targets beyond the reach of other antibody platforms.

Speaking further about the exciting developments at arGEN-X, Mr. Van Hauwermeiren said:

"The signficant progress we have made in 2011 is proof that our unique SIMPLE Antibody™ Platform is tra
'/>"/>

SOURCE arGEN-X
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology
2. arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform
3. arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development
4. arGEN-X Concludes EUR 12.5 Million Series A Financing Round
5. Elan Pharmaceuticals Presents 7th Annual Danville Concours dElegance Weekend
6. Codexis Presents Carbon Capture Update at DoE/NETL Conference
7. Cardium Presents Second Quarter 2011 Financial Results and Reports on Near-Term Milestones
8. Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimers Disease Research
9. Amerigroup Foundation Presents Grant to Rx Partnership
10. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
11. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... N.C. , May 1, 2015 The ... for its high price but manufacturer Gilead Sciences overcame ... worldwide pricing, and effective public relations campaigns. ... of less severe side effects propelled the drug to ... 2014, the therapy,s first quarter on the market. But ...
(Date:5/1/2015)... , May 1, 2015 Hitachi Chemical Diagnostics, ... States launch of the ExoComplete™ 96-Well Plate ... easy system for exosome collection to mRNA purification.  The ... Vesicles ("ISEV") Annual Meeting, April 23 – 26, 2015, ... are intended for research use only of molecular biology ...
(Date:5/1/2015)... Markets ( http://www.researchandmarkets.com/research/63gppw/asian_dermatology ) has announced the addition ... End User - Forecast to 2019" report to their ... to grow at a CAGR of 11.3% from 2014 to ... in the Dermatology devices market around 28.8% in 2014 followed ... market holds a high potential for growth in future due ...
Breaking Medicine Technology:New Study Examines Success Lessons of Sovaldi's and Harvoni's Blockbuster Launches 2New Products for Exosome Isolation to mRNA Purification 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3
... Jan. 26, 2012 Masimo (NASDAQ: MASI ... year financial results for the period ended December 31, 2011, after ... review the results will begin at 1:30 p.m. PT (4:30 p.m. ... Executive Officer, and Mark P. de Raad, Executive Vice President and ...
... Dr. Ira J. Haimowitz, Executive Vice President, Group Director, Intelligence ... at the eMarketing University for Brand Managers, a symposium at ... 2012. The symposium is a full-day course designed ... tactics into their marketing mix. Dr. Haimowitz will be presenting ...
Cached Medicine Technology:Masimo to Report Fourth Quarter and Full Year 2011 Financial Results After Market Close on February 14, 2012 2Masimo to Report Fourth Quarter and Full Year 2011 Financial Results After Market Close on February 14, 2012 3Ira Haimowitz, PhD, EVP, at The CementBloc, to Present on Best Practices in iPad Interactive Selling at 11th Annual ePharma Summit™ 2
(Date:5/3/2015)... “ BolehVPN ” was featured on NewsWatch as part ... coolest technology products available to consumers. Scott Steinberg, a technology ... shared with viewers how to protect their private information. , ... computers and even more so online. It helps everyone stay ... the world. In terms of work, the internet makes things ...
(Date:5/3/2015)... 03, 2015 HealthPostures, a pioneering ... announces its appearance at the , May 5 - ... HealthPostures will exhibit at the conference include its bestselling ... stand solutions is the 6100 TaskMate Executive. Features of ... an adjustable keyboard tray, extended platform work surface and ...
(Date:5/2/2015)... ProText Kinetic 2 is a set of typography creation ... ProText Kinetic 2 features 40 animation presets that ... . Easily create interactive text videos without having to ... 2. , Using ProText Kinetic is as easy as drag ... in the FCPX timeline. Playback the default animation and ...
(Date:5/2/2015)... Chicago, IL (PRWEB) May 02, 2015 Kare ... to provide support for busy caregivers. Kare Visits offers ... hospitals, and assisted living facilities. According to the ... caregivers spend an average of 20 hours a week caring ... fraction of the cost to hire a nurse, a caregiver ...
(Date:5/1/2015)... 02, 2015 The Venetian on Grace ... http://www.thevenetiangracebay.com , and it is elegant and sophisticated, like ... and attractive turquoise hues of Grace Bay Beach. ... percent of leisure travelers used their smartphones throughout the ... used in the planning and researching and continued through ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2
... incorporate health warnings on alcoholic drinks within the next two ... was in talks with the drinks industry on the feasibility ... places where they are sold. ,"I think its ... to depend on the bottle itself and obviously, as I ...
... by the Canadian government a confirmed case of mad-cow disease ... ,The case was of a 6-year-old dairy cow ... national surveillance program for mad-cow disease. ,In a written ... beef. Tissues in which BSE is known to concentrate in ...
... of light and vitamin B2, promises to be an eye ... is well known that almost 10,000 Australians suffer a degenerative ... to blindness. ,The envisaged treatment will entail application of ... eye is removed, and allow the UVA light to fall ...
... The federal agency announced through its web site, on 14th ... the drug Vivitrol (TM), for the treatment of alcoholism. // ... Inc., which will be responsible for the manufacturing of the ... for the drug under an agreement signed June 2005 between ...
... A recent study conducted by researchers at University of Michigan ... of which were presented at the American Association of Cancer ... of drug resistance, a phenomenon that makes cancers difficult to ... spice, ginger could be used in the development of a ...
... whose hunger strike to protest against the raising of the ... doctors attending on her Sunday. // ,"Medha Patkar ... a doctor at the All India Institute of Medical Sciences ... ,AIIMS medical superintendent D.K. Sharma said that ...
Cached Medicine News:Health News:Alcoholism Drug Vivitrol Approved By FDA 2Health News:Alcoholism Drug Vivitrol Approved By FDA 3Health News:Ginger Offers Hope In Ovarian Cancer Fight 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: